Product Information
HYDROXYZINE PAM 25 MG CAP is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0642 per EA under NDC 00555032304. Its NADAC has been published 657 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the Hydroxyzine Pamoate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
25 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00555032304
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
HYDROXYZINE PAMOATEApproval Type
Generic (ANDA)
FDA Application
ANDA088496On Market Since
7/1/1984
Pharmacological Classes
Price Statistics
The NADAC for HYDROXYZINE PAM 25 MG CAP has been published 657 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0642 per EA |
|---|---|
| All-time high | $0.0804 (Feb 12, 2014) |
| All-time low | $0.0540 (Dec 20, 2017) |
| 52-week high | $0.0655 |
| 52-week low | $0.0630 |
| Median price | $0.0662 |
| Average price | $0.0671 |
| Largest weekly change | +20.4% (Jan 22, 2014) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of HYDROXYZINE PAM 25 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for HYDROXYZINE PAM 25 MG CAP, manufactured by Teva Pharmaceuticals USA Inc., is $0.0642 per EA (NDC 00555032304), effective Jun 24, 2026.
How has the price of HYDROXYZINE PAM 25 MG CAP changed over time?
Over the history we have for it, the NADAC for HYDROXYZINE PAM 25 MG CAP has held within roughly two percent of its current level. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for HYDROXYZINE PAM 25 MG CAP?
Since Nov 28, 2013, the NADAC for HYDROXYZINE PAM 25 MG CAP has ranged from a low of $0.0540 (Dec 20, 2017) to a high of $0.0804 (Feb 12, 2014), with a median of $0.0662 per EA.
Are there cheaper alternatives to HYDROXYZINE PAM 25 MG CAP?
4 NADAC-published products share the same active ingredient, strength, and dosage form as HYDROXYZINE PAM 25 MG CAP, but none are currently priced below it.
Who manufactures HYDROXYZINE PAM 25 MG CAP?
HYDROXYZINE PAM 25 MG CAP (NDC 00555032304) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification